Inflammation and cardiovascular risk factors are associated with recurrent thrombosis in antiphospholipid syndrome

被引：0
|
作者：
Saraiva, S. S. [1 ]
Custodio, I. F. [1 ]
Mazzeto, B. M. [1 ]
Collela, M. P. [1 ]
Paula, E., V [2 ]
Appenzeller, S. [2 ]
Annichino-Bizzacchi, J. [2 ]
Orsi, F. A. [3 ,4 ]
机构：
[1] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Sch Med Sci, Dept Clin Med, Campinas, SP, Brazil
[3] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil
[4] Univ Estadual Campinas, Sch Med Sci, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR094
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [21] Risk factors for Antiphospholipid Syndrome (APS) in women with recurrent miscarriage]
    van den Boogaard, E.
    Cohn, D. M.
    Korevaar, J. C.
    Dawood, F.
    Middeldorp, S.
    Goddijn, M.
    Farquharson, R. G.
    HUMAN REPRODUCTION, 2010, 25 : I167 - I167
  • [22] Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis
    Tektonidou, Maria G.
    JOURNAL OF AUTOIMMUNITY, 2022, 128
  • [23] RECURENT THROMBOSIS IN AN ADOLESCENT WITH ANTIPHOSPHOLIPID SYNDROME AND MULT IPLE RISK FACTORS
    Shpitonkova, O. V.
    Podchernyaeva, N. S.
    Kostina, Y. O.
    Manina, M. A.
    NEW ARMENIAN MEDICAL JOURNAL, 2016, 10 (04): : 55 - 60
  • [24] Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome
    Tobaldini, Lais Quinteiro
    Arantes, Fernanda Talge
    Saraiva, Sabrina da Silva
    Mazetto, Bruna de Moraes
    Colella, Marina Pereira
    de Paula, Erich Vinicius
    Annichino-Bizzachi, Joyce
    Orsi, Fernanda Andrade
    THROMBOSIS RESEARCH, 2018, 171 : 114 - 120
  • [25] A retrospective review of 61 patients with antiphospholipid syndrome: Analysis of factors influencing recurrent thrombosis
    KrnicBarrie, S
    OConnor, CR
    Looney, SW
    Pierangeli, SS
    Harris, EN
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (18) : 2101 - 2108
  • [26] Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome
    Hsiao, GR
    Wolf, RE
    Kimpel, DL
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2001, 7 (05) : 336 - 339
  • [27] CARDIOVASCULAR RISK FACTORS IN ANTIPHOSPHOLIPID SYNDROME WITH HYPERTENSION AND RENAL ARTERY STENOSIS
    Horwood, N.
    Sangle, S.
    D'Cruz, D. P.
    Khamashta, M. A.
    Abbs, I.
    Hughes, G. R. V.
    RHEUMATOLOGY, 2004, 43 : 104 - 104
  • [28] Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome
    del-Pino, Rodrigo Aguirre
    Monahan, Rory C.
    Huizinga, Tom W. J.
    Eikenboom, Jeroen
    Steup-Beekman, Gerda M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (06): : 817 - 828
  • [29] Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients With Antiphospholipid Syndrome
    Navarro-Carpentieri, Daniel
    del Carmen Castillo-Hernandez, Maria
    Majluf-Cruz, Karim
    Espejo-Godinez, Guillermo
    Carmona-Olvera, Paola
    Moreno-Hernandez, Manuel
    Lugo-Garcia, Yolanda
    Hernandez-Juarez, Jesus
    Loarca-Pina, Luis
    Isordia-Salas, Irma
    Majluf-Cruz, Abraham
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (05) : 834 - 840
  • [30] The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis
    Torresan, M
    Machado, TFGS
    Siqueira, LH
    Ozelo, MC
    Arruda, VR
    Annichino-Bizzacchi, JM
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (07) : 679 - 682
12345